Sulfinpyrazone

产品说明书

Print
Chemical Structure| 57-96-5 同义名 : 苯磺保泰松 ;G-28315;NSC 75925;Anturanil;Anturane;(+/-)-Sulfinpyrazone
CAS号 : 57-96-5
货号 : A108887
分子式 : C23H20N2O3S
纯度 : 98%
分子量 : 404.481
MDL号 : MFCD00057279
存储条件:

Pure form Sealed in dry,Room Temperature

In solvent -20°C:3-6个月-80°C:12个月

溶解度 :

DMSO: 35 mg/mL(86.53 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

动物实验配方:
生物活性
描述 (±)-Sulfinpyrazone is an orally active and potent uricosuric agent for chronic and intermittent gouty arthritis. Sulfinpyrazone has antithrombotic and platelet inhibitory effects. The normal total dose of sulfinpyrazone as an antithrombotic agent is 800 mg daily. The drug has been used continuously for up to 4 years with no serious adverse reactions or laboratory abnormalities. Sulfinpyrazone is not a substitute for conventional anticoagulant agents (e.g. the coumarin derivatives) in the treatment of venous thrombosis, but is an important drug for the treatment of conditions associated with arterial thrombosis and possibly for the prophylaxis of recurrent venous thrombosis[3]. In rats with kaolin-induced paw oedema this compound is able to restore the markedly prolonged euglobulin clot lysis time in an oral dose of 30 mg/kg, whereas salicylate and dipyridamole are somewhat less active in this respect. Beside these effects, sulfinpyrazone protects rabbits from arachidonate-induced sudden death after a single oral dose of 10 - 30 mg/kg[4].
实验方案
1mg 5mg 10mg

1 mM

5 mM

10 mM

2.47mL

0.49mL

0.25mL

12.36mL

2.47mL

1.24mL

24.72mL

4.94mL

2.47mL

参考文献

[1]Raeder EA, Verrier RL, Lown B. Effects of sulfinpyrazone on ventricular vulnerability in the normal and the ischemic heart. Am J Cardiol. 1982 Aug;50(2):271-5.

[2]Rosenberg JC, Sell TL. In vitro evaluation of inhibitors of platelet release and aggregation. Arch Surg. 1975 Aug;110(8):980-3.

[3]Margulies EH, White AM, Sherry S. Sulfinpyrazone: a review of its pharmacological properties and therapeutic use. Drugs. 1980;20(3):179-197

[4]Rüegg M. Antithrombotic effects of sulfinpyrazone in animals: influence on fibrinolysis and sodium arachidonate-induced pulmonary embolism. Pharmacology. 1976;14(6):522-536